期刊
ONCOTARGET
卷 8, 期 19, 页码 32134-32146出版社
IMPACT JOURNALS LLC
DOI: 10.18632/oncotarget.16739
关键词
epithelial ovarian cancer; metabolomics; plasma; survival; prediction
资金
- National Natural Science Foundation of China [81573256, 81473072, 81472028]
- Natural Science Foundation of Heilongjiang Province [QC2015098]
- Youth Innovation Training Program of Heilongjiang Province [UNPYSCT-2016048]
Epithelial ovarian cancer (EOC) is one of the most lethal gynecological malignancies around the world, and patients with ovarian cancer always have an extremely poor chance of survival. Therefore, it is meaningful to develop a highly efficient model that can predict the overall survival for EOC. In order to investigate whether metabolites could be used to predict the survival of EOC, we performed a metabolic analysis of 98 plasma samples with follow-up information, based on the ultra-performance liquid chromatography mass spectrometry (UPLC/MS) systems in both positive (ESI+)and negative (ESI-) modes. Four metabolites: Kynurenine, Acetylcarnitine, PC (42: 11), and LPE(22: 0/0:0) were selected as potential predictive biomarkers. The AUC value of metabolite-based risk score, together with pathological stages in predicting three-year survival rate was 0.80. The discrimination performance of these four biomarkers between short-term mortality and long-term survival was excellent, with an AUC value of 0.82. In conclusion, our plasma metabolomics study presented the dysregulated metabolism related to the survival of EOC, and plasma metabolites could be utilized to predict the overall survival and discriminate the short-term mortality and long-term survival for EOC patients. These results could provide supplementary information for further study about EOC survival mechanism and guiding the appropriate clinical treatment.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据